Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of 18F-Fluoro-Ethyl-Tyrosine (FET) Positron Emission Tomography (PET) for Grading Glioma

NCT04001257 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.

NCT NCT04001257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04001257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of 18F-Fluoro-Ethyl-Tyrosine (FET) Positron Emission Tomography (PET) for Grading Glioma
Lead sponsor
University Hospital, Brest
Phase
Observational
Overall status
Completed
Start date
June 17, 2019
Completion date
September 17, 2019
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioma, positron emission tomography